![](https://activebeat.com/wp-content/uploads/2012/10/shutterstock_108473003-400x265.jpg)
![](https://activebeat.com/wp-content/uploads/2021/03/cropped-fav-1-150x150.png)
Patients With Ulcerative Colitis Show Improvement With New Drug
According to a clinical trial, more patients with an inflammatory disease of the bowels responded to autoimmune disorder drugs than those taking a placebo. Johnson & Johnson said findings of a trial showed that more patients with severely active ulcerative colitis responded to their drug Simponi (golimumab). The responsiveness to the drug was maintained right […]
1 min read